Search Medical Condition
Please enter condition
Please choose location from dropdown

Merzig-Schwemlingen, Germany Clinical Trials

A listing of Merzig-Schwemlingen, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe

Association of cardiovascular risk factors and ED is likely due to an impairment of endothelial function resulting in a decreased activity of endothelial NO-synthase, which plays a major role in physiology of erection. Heart failure is also known to further contribute to endothelial dysfunction and hence, this could lead to ...

Phase N/A

0.0 miles

Learn More »

Primary Prevention Study: Study on Obesity Cardiovascular and Psycho-Social Characteristics in the City of Merzig

Cardiovascular risk factors and psycho-social characteristics will be determined using a questionnaire in primary care physician offices in the city of Merzig, Germany. We will recruit all people (age>18y) with a body-mass index (BMI) > 30 kg/m2 plus patients in the two following participating physician offices: Praxisnetz and Merzig. Cardiovascular ...

Phase N/A

1.9 miles

Learn More »

Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA

The multi-center, prospective PRODAST study is investigating patients with non-valvular atrial fibrillation (AF) who experienced an ischemic stroke or a transient ischemic attack (TIA) recently ( 1 week) both with and without previous oral anticoagulation. It consists of a baseline visit and a 3 months central follow-up for patients who ...

Phase N/A

1.9 miles

Learn More »

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

This study will look at the change in the participant's body weight from the start to the end of the study. This is to compare the effect on body weight in people taking semaglutide (a new medicine) and people taking "dummy" medicine. In addition to taking the study medicine, the ...

Phase

6.96 miles

Learn More »

Tysabri Observational Program

TOP is an epidemiological observational study of participants receiving natalizumab, with each participant to be followed for up to 10 years. This study is designed to address the long-term safety profile and the long-term impact on disease activity and progression of natalizumab with marketed use, and the impact of treatment ...

Phase N/A

9.39 miles

Learn More »